Loading company…
Respicardia developed an implantable device to treat central sleep apnea.
Respicardia developed the rem ede System, an implantable phrenic nerve stimulator for moderate to severe central sleep apnea in adults. The device is designed to restore normal breathing during sleep without masks or medication. Founded in 2006, the company was based in Minnetonka, US. ZOLL Medical Corporation acquired it in April 2021; financial terms were not disclosed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in